Clinical Trial to be launched

The BWH/Harvard PEG Program is coordinating the launch of a clinical trial for the use of sialidase inhibitors to prevent platelet clearance and to inhibit bacterial proliferation, with intent to broaden the transfusion applicability of longer-storage platelet products.